Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

OPMEDIC Group completes amalgamation and going private transaction

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Confidential Client

On November 6, 2013, OPMEDIC Group Inc., listed on the Toronto Stock Exchange, announced the completion of the amalgamation of OPMEDIC Group and Kemourmedic Acquisition Inc., a wholly-owned subsidiary of Kemourmedic Group Inc., all of the outstanding shares of which are owned by Drs. Pierre St-Michel, Marc Villeneuve and Jean-Yves Fontaine (the Founders), pursuant to which OPMEDIC Group has been taken private. The price offered under the terms of the transaction valued OPMEDIC Group at more than $50 million. OPMEDIC Group provides healthcare-related services including surgical and endoscopic facilities and services to patients and surgeons, fertility treatments, medical imaging, laboratory services and diagnostic procedures. The Founders that took OPMEDIC Group private were represented by Fasken Martineau with a team led by Jean-Pierre Chamberland and that included Jean Michel Lapierre, Joëlle El-Féghali and Caitlin Rose (securities and M&A), Marc Novello, Francis Trifiro and Svetlana Samochkine (banking and finance) and Gilles Carli (tax).

Team

    Subscribe

    Receive email updates from our team

    Subscribe